Ricciuti, Biagio <br/><br/>
Immune Checkpoint Inhibitor Outcomes for Patients With Non-Small-Cell Lung Cancer Receiving Baseline Corticosteroids for Palliative Versus Nonpalliative Indications.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  08 2019 
 - 1927-1934 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.19.00189  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenal Cortex Hormones--administration & dosage<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>B7-H1 Antigen--antagonists & inhibitors<br/>CTLA-4 Antigen--antagonists & inhibitors<br/>Carcinoma, Non-Small-Cell Lung--complications<br/>Disease Progression<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Immune System<br/>Immunotherapy--methods<br/>Lung Neoplasms--complications<br/>Male<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Palliative Care--methods<br/>Prednisone--administration & dosage<br/>Proportional Hazards Models<br/>Pulmonary Disease, Chronic Obstructive--complications<br/>Radiation Pneumonitis--complications<br/>Retrospective Studies<br/>Treatment Outcome